Most people, if they've heard of vitamin K, know it as something related to helping with blood clotting. But new research has discovered a range of other benefits relating to increased vitamin K2 intake when it comes to improving health and longevity.
Vitamin K activates a protein that helps prevent calcium from depositing in your arteries. Several observational studies have suggested that vitamin K2 is better than K1 at reducing these calcium deposits and lowering your risk of heart disease. In fact, studies have shown that taking a supplement in the form of MenaQ7® can not only prevent vascular damage in people over the age of 55, it can also help recover arteries from pre -existing stiffening.
Researchers have identified three factors contributing to improved cardio test results after people have been taking K2 MK-7:
There are a number of forms of vitamin K2 available which are designated by 'MK'. The form that is clinically proven to be most effective, particularly for cardiovascular and bone benefits is designated MK-7.
There are multiple manufacturers of Vitamin K2 MK-7 however, there are question marks over the stability and thus the efficacy of many of these products. As an example, in a recent survey carried out in Europe it was found that 80% of the products that were purchased off the shelf and tested had no traces of the MK-7 Vitamin K2 present. This was not due to the ingredient not being included at the stage when the supplement was manufactured, but rather because of the instability of the MK-7 it had degraded to the point of being inactive.
We found and selected the most stable and proven form possible by the original inventors of MK-7, MenaQ7PURE® by NattoPharma manufactured in Europe. This is the ingredient that holds world-wide patents and has conducted the overwhelming majority of the clinical trials. For even greater 'insurance' we are using the form that is micro-encapsulated which guarantees stability.
"Every day there's a little battle taking place inside our arteries..."
In this video, one of Xtend-Life's researchers, Ivor Cummins, interviews Dr Hogna Vik covering all things vitamin K, in particular the role it plays in cardiovascular health.
Ivor is a researcher holding a number of positions, including Chief Program Officer for Irish Heart Disease Awareness. Dr Hogna, the Chief Scientist and CEO of Nattopharma, is probably the world's foremost expert on vitamin K2.
MenaQ7® not only prevents vascular damage, it also helps recover arteries from pre-existing stiffening.
This document contains links to published clinical studies, multiple references and much more.
CoQ10 (Coenzyme Q10) is currently one of the most popular dietary supplements globally. Approximately 45% of cardiologists recommend CoQ10 to their patients – more than double that of other supplements. It’s also among the top five supplements ...
Shipping calculated at checkout